Drug
Afxl Assisted Ingenol Mebutate Delivery
Afxl Assisted Ingenol Mebutate Delivery: highest development phase Phase 1/2, developed by LEO Pharma. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- LEO Pharma
Trials
| Drug | Phase | Indication |
|---|---|---|
| AFXl-assisted ingenol mebutate delivery NCT03569345 | Phase 1/2 | Carcinoma, Basal Cell |
Latest
No recent events.
Follow Afxl Assisted Ingenol Mebutate Delivery on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.